I really don't see Elan being independent for very long is the credit squeeze continues.
I've fought with many guys on the imclone board that Elan would see $7 while it was trading north of $25. Well reality set set and it's now @ $6.75.
They were trying to sell one of their divisions but they pull that off the market in these conditions.
They do have an debt problem so it wouldn't surprise me if Biogen or even Wythe take a look. If Wythe looks that would be provide a promising view of BAP.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.